Licensed use — if any
No consumer body-composition, recovery or anti-ageing indication is established on this page. Earlier human trials do not equal marketing authorisation.
Preview openPlanned full launch in
--Days--Hrs--Min--Sec
← Peptide Intelligence
Ghrelin-receptor agonist / growth hormone secretagogue
Ipamorelin
A growth hormone secretagogue studied as a ghrelin-receptor agonist, including trials in post-operative gastrointestinal recovery.
Research interest
Growth hormone signalling and post-operative gastrointestinal motility. These research settings are different from online performance claims.
Evidence lens
Known does not mean proven for everything.
The strongest claim on the page should never be stronger than the strongest source behind it.
- ClinicalTrials.gov records completed phase 2 studies in post-operative gastrointestinal recovery.
- Human exposure exists, but it does not establish a licensed physique or longevity treatment.
- FDA has highlighted limited safety information for proposed injectable routes.
- Long-term safety in healthy users.
- A reliable benefit–risk profile for body composition, sleep or recovery claims.
- Quality and impurity profile of non-regulated material.
- FDA cites immunogenicity, aggregation and peptide-impurity concerns.
- FDA also notes serious adverse events, including death, in an intravenous gastric-motility study; this does not prove safety for other routes.
- No self-administration protocol is provided here.
Regulatory snapshot
Jurisdiction and context matter.
Not presented here as a UK-authorised medicine. Check the MHRA database and obtain professional regulatory advice before any supply claim.
Investigational; not an FDA-approved consumer performance or anti-ageing treatment.
Ipamorelin is captured by WADA's prohibition of growth hormone-releasing peptides under S2.
Primary sources
Open the record.
Statuses change. Always check the current regulator, product label, trial record and anti-doping list.
Do not start, stop or source a medicine based on this page. Speak to a qualified healthcare professional and use regulated supply routes. Call 999 in an emergency or NHS 111 for urgent advice.
Continue through the library →